<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="41904">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02560844</url>
  </required_header>
  <id_info>
    <org_study_id>08-0638</org_study_id>
    <nct_id>NCT02560844</nct_id>
  </id_info>
  <brief_title>Cardiomyopathy Arrhythmia Risk Evaluation</brief_title>
  <acronym>CARE</acronym>
  <official_title>Cardiomyopathy Arrhythmia Risk Evaluation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the prognostic utility of novel ECG markers of electrical
      instability in patients with cardiomyopathy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Baseline ECG markers of electrical instability will be measured in patients with
      cardiomyopathy. These ECG markers will be evaluated from a clinical Holter recording. All
      patients will have a primary implantable cardioverter defibrillator (ICD) as part of their
      clinical care. Patients will be followed prospectively for 2 years to evaluate the primary
      outcome of appropriate ICD shocks. Multivariable modelling will be performed to determine
      whether the ECG markers of electrical instability independently predict the primary clinical
      outcome.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of patients with appropriate implantable cardioverter defibrillator (ICD) shocks</measure>
    <time_frame>2 years</time_frame>
    <description>Proportion is from 0 (no patients with shocks) to 100% (all patients receive shocks)</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Cardiomyopathy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with cardiomyopathy and primary prevention ICDs
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  cardiomyopathy, primary prevention ICD

        Exclusion Criteria:

          -  brady-pacing requirement
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Vijay Chauhan, MD</last_name>
    <phone>416-340-3172</phone>
    <email>vijay.chauhan@uhn.on.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Health Network</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 2C4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vijay Chauhan, MD</last_name>
      <phone>416-340-3172</phone>
      <email>vijay.chauhan@uhn.on.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <lastchanged_date>May 24, 2016</lastchanged_date>
  <firstreceived_date>September 21, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cardiomyopathies</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
